PhII ICb With/Without Erbitux in MBC Pts

Clinical trial NCT00248287 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT00248287
Sponsor: US Oncology Research
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Breast Cancer

Start date: 2005-07-28
Primary completion: 2025-12-01
Enrollment: 154

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.